欢迎来到天天文库
浏览记录
ID:18358441
大小:236.56 KB
页数:3页
时间:2018-09-16
《中药血管抑制剂人参皂苷rg3联合紫杉醇治疗胃癌术后肝转移的研究》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库。
1、万方数据中华医药884学刊第26卷第4期2008年4月中华中医药学刊CHINESEARCHIVES‘OFTRADITIONALCHINESEMEDICINEv01.26NO.4Apr.208中药血管抑制剂人参皂苷R93联合紫杉醇治疗胃癌术后肝转移的研究袁国荣1”,叶再元2(1.浙江中医药大学,浙江杭州310053;2.浙江省人民医院,浙江杭州310014)摘要:目的:探讨中药血管抑制剂人参皂苷R93联合紫杉醇治劳胃癌术后肝转移的临床疗效。方法:39例胃癌术后肝转移患者随机分为治疗组18例,采用中药血管抑制荆人参皂苷a
2、93联合紫杉醇为主化疗,对照组2l例,采用单纯紫衫醇为主化疗。结果:治疗组总有效率(CR+PR)迭66.6%,对照组42.8%。两组比较有显著性差异(P<0.05);两组治疗后血清血管内皮生长因子(VEGF)均有下降,治疗组下降更明显(P<0.01);治疗组在保护免疫功能方面优于化疗组,两组比较有显著性差异(P<0.01);治疗组中位生存期及中位疾病进展时问较对照组延长,两组中住生存期及中位疾病进展时间比较有显著性差异(P3、免疫功能,延长中住生存期及中位痰病进展时间。关键词:胃肿瘤;肝转移;中药血管抑制荆;人参皂苷R93;紫杉醇中图分类号:R285.5文献标识码:B文章编号:1673—7717(2008)04—0884—03R93combinedwithPaclitaxelChemotherapyonthePatientswithGastricCarcinomaafterSurgeryandLiverMetastasisYUANGuo-ron91一,YEZai.Yuan2(1.ZhejiangChineseMedicalUniversi4、ty,Hangzhou310053.Zhanzho,China;2.ZhejiangProvincePeopleHospital,H¨gzhou310014,Zhejiang,China)Abstract:0bjective:ToinvestigatetheelinicalbenefitofChinesetraditionalmedicinevasinhibitorGinsenoside(R93)combinedwithPaclitaxelchemotherapyonthepatientswithgastriccar5、cinomaaftersurgeryandlivermetastasis.Methods:39patientswithgastriccarcinomaandlivermetastasisweredividedinto2groupsrandomly。Amongthem.18patientsreceivedGinsenoside(R庐)combinedwithpaelitaxelchemotherapy,thecontrolgroup,21patientsweretreatedwithpaelitaxelchemothe6、rapyalone.Results:theoverallresponserateofthetherapygroup(CRandPR)WaS66.6%,whilethecontrolgroupWas42.8%,significantdifferencewasobservedbetweenthetWOgroups(P<0.05);thelevelofVEGFWaSdecreasedinbothofgroups,whichofthetherapygroupwagobviouslylowerthanthatofthecont7、rolgroup(P<0.01);ProtectingimmunityabilityofthetherapygroupWassignificantlyhigherthanthatofthechemotherapygroup(P<0.01);TherewassignificantdifferencebetweenPFSand耵'Pofthetwogroups(P<0.05),期限andPFSofthetherapygroupwerelongerthanthatofthecontrolgroup.Conclusion:G8、insenoside(瞄)combinedwithPaclitaxelehem·otherapytreatsthepatientswithgastriccarcinomaaftersurgeryandlivermetastasiswhichmaybehelpfulinenhancingtheoveralleffectiverate.protec
3、免疫功能,延长中住生存期及中位痰病进展时间。关键词:胃肿瘤;肝转移;中药血管抑制荆;人参皂苷R93;紫杉醇中图分类号:R285.5文献标识码:B文章编号:1673—7717(2008)04—0884—03R93combinedwithPaclitaxelChemotherapyonthePatientswithGastricCarcinomaafterSurgeryandLiverMetastasisYUANGuo-ron91一,YEZai.Yuan2(1.ZhejiangChineseMedicalUniversi
4、ty,Hangzhou310053.Zhanzho,China;2.ZhejiangProvincePeopleHospital,H¨gzhou310014,Zhejiang,China)Abstract:0bjective:ToinvestigatetheelinicalbenefitofChinesetraditionalmedicinevasinhibitorGinsenoside(R93)combinedwithPaclitaxelchemotherapyonthepatientswithgastriccar
5、cinomaaftersurgeryandlivermetastasis.Methods:39patientswithgastriccarcinomaandlivermetastasisweredividedinto2groupsrandomly。Amongthem.18patientsreceivedGinsenoside(R庐)combinedwithpaelitaxelchemotherapy,thecontrolgroup,21patientsweretreatedwithpaelitaxelchemothe
6、rapyalone.Results:theoverallresponserateofthetherapygroup(CRandPR)WaS66.6%,whilethecontrolgroupWas42.8%,significantdifferencewasobservedbetweenthetWOgroups(P<0.05);thelevelofVEGFWaSdecreasedinbothofgroups,whichofthetherapygroupwagobviouslylowerthanthatofthecont
7、rolgroup(P<0.01);ProtectingimmunityabilityofthetherapygroupWassignificantlyhigherthanthatofthechemotherapygroup(P<0.01);TherewassignificantdifferencebetweenPFSand耵'Pofthetwogroups(P<0.05),期限andPFSofthetherapygroupwerelongerthanthatofthecontrolgroup.Conclusion:G
8、insenoside(瞄)combinedwithPaclitaxelehem·otherapytreatsthepatientswithgastriccarcinomaaftersurgeryandlivermetastasiswhichmaybehelpfulinenhancingtheoveralleffectiverate.protec
此文档下载收益归作者所有